Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

A Web-based communication aid for patients with cancer: the CONNECT Study.

Meropol NJ, Egleston BL, Buzaglo JS, Balshem A, Benson AB 3rd, Cegala DJ, Cohen RB, Collins M, Diefenbach MA, Miller SM, Fleisher L, Millard JL, Ross EA, Schulman KA, Silver A, Slater E, Solarino N, Sulmasy DP, Trinastic J, Weinfurt KP.

Cancer. 2013 Apr 1;119(7):1437-45. doi: 10.1002/cncr.27874. Epub 2013 Jan 18.

2.

Predictors of patient uptake of colorectal cancer gene environment risk assessment.

Hall MJ, Manne SL, Myers RE, Keenan EM, Balshem AM, Weinberg DS.

Genome Med. 2012 Nov 29;4(11):92. doi: 10.1186/gm393. eCollection 2012.

3.

A pilot study for using fecal immunochemical testing to increase colorectal cancer screening in Appalachia, 2008-2009.

Kluhsman BC, Lengerich EJ, Fleisher L, Paskett ED, Miller-Halegoua SM, Balshem A, Bencivenga MM, Spleen AM, Schreiber P, Dignan MB.

Prev Chronic Dis. 2012;9:E77.

4.

Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors.

Miller SM, Roussi P, Daly MB, Buzaglo JS, Sherman K, Godwin AK, Balshem A, Atchison ME.

Health Educ Behav. 2005 Oct;32(5):654-67.

PMID:
16148211
5.

A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.

Baffoe-Bonnie AB, Smith JR, Stephan DA, Schleutker J, Carpten JD, Kainu T, Gillanders EM, Matikainen M, Teslovich TM, Tammela T, Sood R, Balshem AM, Scarborough SD, Xu J, Isaacs WB, Trent JM, Kallioniemi OP, Bailey-Wilson JE.

Hum Genet. 2005 Aug;117(4):307-16. Epub 2005 May 20. Erratum in: Hum Genet. 2005 Nov;118(2):307.

PMID:
15906096
6.

Change in worksite smoking behavior following cancer risk feedback: a pilot study.

Schnoll RA, Wang H, Miller SM, Babb JS, Cornfeld MJ, Tofani SH, Hennigan-Peel T, Balshem A, Slater E, Ross E, Boyd CS, Engstrom PF.

Am J Health Behav. 2005 May-Jun;29(3):215-27.

PMID:
15899685
7.

An exploration of relative health stock in advanced cancer patients.

Gaskin DJ, Weinfurt KP, Castel LD, DePuy V, Li Y, Balshem A, Benson A, Burnett CB, Corbett S, Marshall J, Slater E, Sulmasy DP, Van Echo D, Meropol NJ, Schulman KA.

Med Decis Making. 2004 Nov-Dec;24(6):614-24.

PMID:
15534342
8.

The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.

Weinfurt KP, Castel LD, Li Y, Sulmasy DP, Balshem AM, Benson AB 3rd, Burnett CB, Gaskin DJ, Marshall JL, Slater EF, Schulman KA, Meropol NJ.

Cancer. 2003 Jul 1;98(1):166-75.

9.

Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication.

Meropol NJ, Weinfurt KP, Burnett CB, Balshem A, Benson AB 3rd, Castel L, Corbett S, Diefenbach M, Gaskin D, Li Y, Manne S, Marshall J, Rowland JH, Slater E, Sulmasy DP, Van Echo D, Washington S, Schulman KA.

J Clin Oncol. 2003 Jul 1;21(13):2589-96.

PMID:
12829680
10.

A training course for oncology nurses in familial cancer risk assessment: evaluation of knowledge and practice.

Masny A, Daly M, Ross E, Balshem A, Gillespie D, Weil S.

J Cancer Educ. 2003 Spring;18(1):20-5.

PMID:
12825630
11.

Implementation of a comprehensive cancer control program at the worksite: year one summary report.

Cornfeld MJ, Schnoll RA, Tofani SH, Babb JS, Miller SM, Henigan-Peel T, Balshem A, Slater E, Ross E, Siemers S, Montgomery S, Malstrom M, Hunt P, Boyd S, Engstrom PF.

J Occup Environ Med. 2002 May;44(5):398-406.

PMID:
12024685
12.

Chronic dosing of oltipraz in people at increased risk for colorectal cancer.

Szarka CE, Yao KS, Pfeiffer GR, Balshem AM, Litwin S, Frucht H, Goosenberg EB, Engstrom PF, Clapper ML, O'Dwyer PJ.

Cancer Detect Prev. 2001;25(4):352-61.

PMID:
11531012
13.

Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population.

Simunovic M, To T, Baxter N, Balshem A, Ross E, Cohen Z, McLeod R, Engstrom P, Sigurdson E.

J Gastrointest Surg. 2000 May-Jun;4(3):324-30.

PMID:
10769097
14.

Exploring family relationships in cancer risk counseling using the genogram.

Daly M, Farmer J, Harrop-Stein C, Montgomery S, Itzen M, Costalas JW, Rogatko A, Miller S, Balshem A, Gillespie D.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):393-8.

15.

Prostate cancer risk assessment program. A model for the early detection of prostate cancer.

Bruner DW, Baffoe-Bonnie A, Miller S, Diefenbach M, Tricoli JV, Daly M, Pinover W, Grumet SC, Stofey J, Ross E, Raysor S, Balshem A, Malick J, Engstrom P, Hanks GE, Mirchandani I.

Oncology (Williston Park). 1999 Mar;13(3):325-34; discussion 337-9, 343-4 pas.

16.

Clinical relevance of chromosome abnormalities in non-small cell lung cancer.

Feder M, Siegfried JM, Balshem A, Litwin S, Keller SM, Liu Z, Testa JR.

Cancer Genet Cytogenet. 1998 Apr 1;102(1):25-31.

PMID:
9530336
17.

Implications of fine-needle aspiration in patients with resectable pancreatic cancer.

Johnson DE, Pendurthi TK, Balshem AM, Ross E, Litwin S, Eisenberg BL, Hoffman JP.

Am Surg. 1997 Aug;63(8):675-9; discussion 679-80.

PMID:
9247432
18.

Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity.

Clapper ML, Szarka CE, Pfeiffer GR, Graham TA, Balshem AM, Litwin S, Goosenberg EB, Frucht H, Engstrom PF.

Clin Cancer Res. 1997 Jan;3(1):25-30.

19.

Employee response to a company-sponsored program of colorectal and prostate cancer screening.

Myers RE, Vernon SW, Carpenter AV, Balshem AM, Lewis PG, Wolf TA, Hilbert J, DeFonso LR, Ross EA.

Cancer Detect Prev. 1997;21(4):380-9.

PMID:
9232330
20.

Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.

O'Dwyer PJ, Szarka CE, Yao KS, Halbherr TC, Pfeiffer GR, Green F, Gallo JM, Brennan J, Frucht H, Goosenberg EB, Hamilton TC, Litwin S, Balshem AM, Engstrom PF, Clapper ML.

J Clin Invest. 1996 Sep 1;98(5):1210-7.

21.

Results of an office-based training program in clinical breast examination for primary care physicians.

Benincasa TA, King ES, Rimer BK, Bloom HS, Balshem A, James J, Engstrom PF.

J Cancer Educ. 1996 Spring;11(1):25-31.

PMID:
8777152
22.

Mammography interventions for 65- to 74-year-old HMO women. Program effectiveness and predictors of use.

King ES, Ross E, Seay J, Balshem A, Rimer B.

J Aging Health. 1995 Nov;7(4):529-51.

PMID:
10165968
23.

Community physician willingness to refer cancer patients for treatment education.

Myers RE, Wolf TA, Ross EA, Balshem A, Fried B, Kaluzny AD.

Ann N Y Acad Sci. 1995 Sep 30;768:323-6. No abstract available.

PMID:
8526378
24.

Interest in genetic testing among first-degree relatives of breast cancer patients.

Lerman C, Seay J, Balshem A, Audrain J.

Am J Med Genet. 1995 Jul 3;57(3):385-92.

PMID:
7677139
25.

Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer.

Szarka CE, Pfeiffer GR, Hum ST, Everley LC, Balshem AM, Moore DF, Litwin S, Goosenberg EB, Frucht H, Engstrom PF, et al.

Cancer Res. 1995 Jul 1;55(13):2789-93.

26.

Effects of individualized breast cancer risk counseling: a randomized trial.

Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, Balshem A.

J Natl Cancer Inst. 1995 Feb 15;87(4):286-92.

PMID:
7707420
27.

Receptivity of African-American men to prostate cancer screening.

Myers RE, Wolf TA, Balshem AM, Ross EA, Chodak GW.

Urology. 1994 Apr;43(4):480-7.

PMID:
8154068
28.

Attitudes about genetic testing for breast-ovarian cancer susceptibility.

Lerman C, Daly M, Masny A, Balshem A.

J Clin Oncol. 1994 Apr;12(4):843-50.

PMID:
8151327
29.

Recruiting high risk women into a breast cancer health promotion trial.

Lerman C, Rimer BK, Daly M, Lustbader E, Sands C, Balshem A, Masny A, Engstrom P.

Cancer Epidemiol Biomarkers Prev. 1994 Apr-May;3(3):271-6.

30.

Modeling adherence to colorectal cancer screening.

Myers RE, Ross E, Jepson C, Wolf T, Balshem A, Millner L, Leventhal H.

Prev Med. 1994 Mar;23(2):142-51. Erratum in: Prev Med 1994 Jul;23(4):545.

PMID:
8047519
31.

Promoting mammography use through progressive interventions: is it effective?

King ES, Rimer BK, Seay J, Balshem A, Engstrom PF.

Am J Public Health. 1994 Jan;84(1):104-6.

32.

Screening for colorectal neoplasia: physicians' adherence to complete diagnostic evaluation.

Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L.

Am J Public Health. 1993 Nov;83(11):1620-2.

33.
34.

Mammography adherence and psychological distress among women at risk for breast cancer.

Lerman C, Daly M, Sands C, Balshem A, Lustbader E, Heggan T, Goldstein L, James J, Engstrom P.

J Natl Cancer Inst. 1993 Jul 7;85(13):1074-80.

PMID:
8515494
35.

Adherence to continuous screening for colorectal neoplasia.

Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L.

Med Care. 1993 Jun;31(6):508-19.

PMID:
8501998
36.

Impact of an HMO-based intervention to increase mammography utilization.

Trock B, Rimer BK, King E, Balshem A, Cristinzio CS, Engstrom PF.

Cancer Epidemiol Biomarkers Prev. 1993 Mar-Apr;2(2):151-6.

37.

Mammography-related beliefs of older women. A survey of an HMO population.

King E, Rimer BK, Balshem A, Ross E, Seay J.

J Aging Health. 1993 Feb;5(1):82-100.

PMID:
10123496
38.

Feasibility of a telephone survey to recruit health maintenance organization members into a tamoxifen chemoprevention trial.

Daly M, Seay J, Balshem A, Lerman C, Engstrom P.

Cancer Epidemiol Biomarkers Prev. 1992 Jul-Aug;1(5):413-6.

39.

Breast cancer screening: effect of physician specialty, practice setting, year of medical school graduation, and sex.

Turner BJ, Amsel Z, Lustbader E, Schwartz JS, Balshem A, Grisso JA.

Am J Prev Med. 1992 Mar-Apr;8(2):78-85.

PMID:
1599724
40.

Behavioral interventions to increase adherence in colorectal cancer screening.

Myers RE, Ross EA, Wolf TA, Balshem A, Jepson C, Millner L.

Med Care. 1991 Oct;29(10):1039-50.

PMID:
1921523
41.

How valid are mammography self-reports?

King ES, Rimer BK, Trock B, Balshem A, Engstrom P.

Am J Public Health. 1990 Nov;80(11):1386-8.

42.

Factors associated with repeat adherence to breast cancer screening.

Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF.

Prev Med. 1990 May;19(3):279-90.

PMID:
2377590
43.

Breast screening practices among primary physicians: reality and potential.

Rimer BK, Trock B, Balshem A, Engstrom PF, Rosan J, Lerman C.

J Am Board Fam Pract. 1990 Jan-Mar;3(1):26-34.

PMID:
2305638
44.

The experience of cancer warning signs in a general population and its implications for public education.

Balshem AM, Amsel Z, Workman S, Engstrom P.

Prog Clin Biol Res. 1988;278:77-89. No abstract available.

PMID:
3211947
45.

Development of a nutrition education program for a blue collar community.

Balshem M, Amsel Z, Workman S, Balshem A, Engstrom P.

Prog Clin Biol Res. 1988;278:65-76. No abstract available.

PMID:
3211945
46.

Cancer control in a defined population: results of the "Beat the Odds" education campaign.

Workman S, Amsel Z, Balshem A, Engstrom P.

Prog Clin Biol Res. 1988;278:55-64. No abstract available.

PMID:
3211944
47.

Dimensions of disease and health promotion implications: comparing images of cancer and heart disease in a blue collar community.

Amsel Z, Balshem AM, Balshem MM, Workman SW, Goldberg-Alberts R, Engstrom PF.

Prog Clin Biol Res. 1988;278:43-54. No abstract available.

PMID:
3211943
48.

Comparative methodologies for the community distribution of a cancer risk assessment form.

Balshem AM, Amsel Z, Gillespie D, Guidera-Matey A, Engstrom P.

Prog Clin Biol Res. 1987;248:161-72. No abstract available.

PMID:
3671404
49.

Cancer related attitudes and practices in a community experiencing high cancer mortality.

Amsel Z, Balshem AM, Gillespie D, Grover PL, Engstrom PF.

Prog Clin Biol Res. 1986;216:247-61. No abstract available.

PMID:
3725791
50.

The impact of physician reinforcement on breast self-examination practice.

Amsel Z, Grover PL, Balshem AM.

J Fam Pract. 1984 Aug;19(2):236-8. No abstract available.

PMID:
6747567

Supplemental Content

Loading ...
Support Center